FDA OKs Laser Hair-Removal Device for Home Use
SpectraGenics, a Pleasanton, Calif.-based maker of aesthetic lasers, today announced over-the-counter (OTC) clearance from the US Food and Drug Administration (FDA) for its patented handheld laser hair-removal device for home use. The Tria will be the first such laser on the US market, the company said, and features a diode laser designed for consumer use. "The FDA clearance is the culmination of many years of research, clinical testing and innovative product design efforts," said Robert Grove, PhD, CEO, SpectraGenics. "Our engineers are the same scientists who developed the first and gold-standard professional diode laser hair-removal system over 10 years ago which is still used by physicians nationwide. We've invested significant resources to harness that same light-based technology to deliver a safe, effective way for consumers to treat unwanted hair in the privacy of their homes." SpectraGenics has been selling a version of the Tria, called i-Epi, in Japan since 2005; Tria will be available in the US this spring.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024